| TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
9.43 |
Evidence |
O
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
9.387 |
Evidence |
O
|
| F2 |
F2: Prothrombin precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
9.35 |
Evidence |
O
|
| MSN |
MSN: Moesin |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
9.325 |
Evidence |
O
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
9.325 |
Evidence |
O
|
| GPI |
GPI: Glucose-6-phosphate isomerase |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
9.322 |
Evidence |
|
| SRF |
SRF: Serum response factor |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
9.322 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
9.297 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
9.177 |
Evidence |
O
|
| GHR |
GHR: Growth hormone receptor precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
9.142 |
Evidence |
|
| IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
9.142 |
Evidence |
O
|
| LDB3 |
LDB3, KIAA0613, ZASP: LIM domain-binding protein 3 |
ACTN2 |
ACTN2: Alpha-actinin-2 |
9.047 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
9.0 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
9.0 |
Evidence |
O
|
| LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
SNRPD1 |
SNRPD1: Small nuclear ribonucleoprotein Sm D1 |
8.98 |
Evidence |
|
| U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
8.98 |
Evidence |
O
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
8.962 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
8.962 |
Evidence |
O
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRLR |
PRLR: Prolactin receptor precursor |
8.962 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
8.927 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
8.927 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
RELA |
RELA, NFKB3: Transcription factor p65 |
8.927 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
8.927 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
8.927 |
Evidence |
|
| SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
8.927 |
Evidence |
|
